On the recordJuly 19, 2006
I rise today with Senators Schumer and Leahy to introduce an important piece of legislation for seniors, individual with disabilities, children, and anyone who is taking a brand name prescription drug with a generic equivalent. The bill we are introducing today would outlaw the latest in a long line of loopholes that brand name manufacturers have found to limit generic drug access to the market. Our legislation would prohibit brand name manufacturers from introducing so-called ``authorized generics'' during the 180-day period that Congress intended true generics to have exclusive market rights. Some of my colleagues may be wondering what an ``authorized generic'' is. An authorized generic drug is a brand name prescription drug produced by the same brand manufacturer on the same manufacturing lines, yet repackaged as a generic in order to confuse consumers and shut true generics out of the market. This is a huge problem and one that is becoming even more prevalent as patents on some of the best-selling brand name pharmaceuticals start to expire. Pravachol, Zocor and Zoloft have patents that have expired or will expire this year. Together, these drugs account for approximately $9 billion in sales annually. In 2007, another top-selling brand name drug, Norvasc, will lose its patent protection, followed by Advair the following year.…
Source
govinfo.gov




